Fact based stock research
Align (NasdaqGS:ALGN)


Align stock research in summary

aligntech.com


Align shares have a HOLD rating. They show above average growth and are safely financed, but are bad value. We recommend holding Align shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Supplies
Index NASDAQ, S&P 500, D.J. US Medical Equipment
Size class X-Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock






 

Research History: Align

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
33
9
14
10
STOCK GROWTH RANKS
58
93
92
94
STOCK SAFETY RANKS
58
65
96
53
COMBINED STOCK RANKS
46
60
88
66

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Align in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Align; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
57
73
90
92
PROFIT GROWTH
47
70
65
64
STOCK RETURNS
53
98
87
96
CONSOLIDATED RANK: GROWTH
58
93
92
94

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Align.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
80
88
59
55
REFINANCING
2
4
LIQUIDITY
32
26
92
94
CONSOLIDATED RANK: SAFETY
58
65
96
53

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Align and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Align from March 22, 2018.